Related references
Note: Only part of the references are listed.Whole body application of a potent topical corticosteroid for bullous pemphigoid
J. B. Terra et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
Inhibition of Putative Hyalurosome Platform in Keratinocytes as a Mechanism for Corticosteroid-Induced Epidermal Atrophy
Laurent Barnes et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Glucocorticoid-induced cutaneous adverse events
B. Guillot
REVUE DE MEDECINE INTERNE (2013)
Management of Difficult-to-Treat Atopic Dermatitis
Peter D. Arkwright et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2013)
Prevalence of dermatoporosis in elderly French hospital in-patients: a cross-sectional study
V. Mengeaud et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
In vivo multiphoton imaging of human skin: assessment of topical corticosteroid-induced epidermis atrophy and depigmentation
Hassan Ait El Madani et al.
JOURNAL OF BIOMEDICAL OPTICS (2012)
Glucocorticosteroids: current and future directions
Peter J. Barnes
BRITISH JOURNAL OF PHARMACOLOGY (2011)
A systematic review of tacrolimus ointment compared with corticosteroids in the treatment of atopic dermatitis
A. Svensson et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Rapid non-genomic effects of corticosteroids and their role in the central stress response
Femke L. Groeneweg et al.
JOURNAL OF ENDOCRINOLOGY (2011)
Molecular aspects of skin ageing
Elizabeth C. Naylor et al.
MATURITAS (2011)
Retinyl retinoate induces hyaluronan production and less irritation than other retinoids
Jin Eun Kim et al.
JOURNAL OF DERMATOLOGY (2010)
Dermal Hyaluronan Is Rapidly Reduced by Topical Treatment with Glucocorticoids
Carl Gebhardt et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Cosmeceuticals: The Evidence Behind the Retinoids
Kajal Babamiri et al.
AESTHETIC SURGERY JOURNAL (2010)
Topical Corticosteroids and Topical Calcineurin Inhibitors in the Treatment of Atopic Dermatitis: Focus on Percutaneous Absorption
David Pariser
AMERICAN JOURNAL OF THERAPEUTICS (2009)
Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial
K. Kragballe et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis
Jens-Michael Jensen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
A Comparison of Two Regimens of Topical Corticosteroids in the Treatment of Patients with Bullous Pemphigoid: A Multicenter Randomized Study
Pascal Joly et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
A multitechnique evaluation of topical corticosteroid treatment
G. Josse et al.
SKIN RESEARCH AND TECHNOLOGY (2009)
Hyaluronan in skin: aspects of aging and its pharmacologic modulation
Robert Stern et al.
CLINICS IN DERMATOLOGY (2008)
Targeted and combination treatments for vitiligo - Comparative evaluation of different current modalities in 458 subjects
Torello Lotti et al.
DERMATOLOGIC THERAPY (2008)
All-trans retinoic acid-induced hyaluronan production and hyperplasia are partly mediated by EGFR signaling in epidermal Keratinocytes
Sanna M. Pasonen-Seppanen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Intrinsic and extrinsic factors in skin ageing: a review
M. A. Farage et al.
INTERNATIONAL JOURNAL OF COSMETIC SCIENCE (2008)
New frontiers in the pharmacological management or Parkinson's disease
Mildred D. Gottwald et al.
DRUGS OF TODAY (2008)
Clobetasol propionate - Where, when, why?
Ragna Pels et al.
DRUGS OF TODAY (2008)
Dermatoporosis: A chronic cutaneous insufficiency/fragility syndrome
Gurkan Kaya et al.
DERMATOLOGY (2007)
Action of topical thyroid hormone analogue, triiodothyroacetic acid in reversing glucocorticoid-induced skin atrophy in humans
Parviz Yazdanparast et al.
THYROID (2006)
Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial
M. Cossmann et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet®/Daivobet®/Taclonex®) in the treatment of psoriasis vulgaris
K. Kragballe et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Glucocorticoid therapy-induced skin atrophy
S Schoepe et al.
EXPERIMENTAL DERMATOLOGY (2006)
Adverse effects of topical glucocorticosteroids
UR Hengge et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis - Review of randomised, double-blind clinical studies conducted in Japan
Hidemi Nakagawa
CLINICAL DRUG INVESTIGATION (2006)
A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis
S Reitamo et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: A randomized comparison of efficacy and safety in subjects with scalp psoriasis
P Reygagne et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2005)
Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial
D Rigopoulos et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Effects of 1-year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitis
H Kyllönen et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
An open-label study of the safety and efficacy of limited application of fluticasone propionate ointment, 0.005%, in patients with atopic dermatitis of the face and intertriginous areas
MH Tan et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2002)
Mechanisms involved in the side effects of glucocorticoids
H Schäcke et al.
PHARMACOLOGY & THERAPEUTICS (2002)
Different skin thinning potential of equipotent medium-strength glucocorticoids
HC Korting et al.
SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY (2002)
A pilot study to determine, the effect of tazarotene gel 0.1% on steroid-induced epidermal atrophy
K Kaidbey et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2001)
Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin
L Kolbe et al.
SKIN RESEARCH AND TECHNOLOGY (2001)
Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas
MG Lebwohl et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2001)
Share Paper
